health
prnewswire_all
6/26/2026
Revision Skincare® Appoints Marco Ficarelli as Chief Global Growth Officer
Revision Skincare® Appoints Marco Ficarelli as Chief Global Growth Officer
wecharge.inopticare.in
health
prnewswire_all
6/26/2026
SAMARITAN'S PURSE DEPLOYS EMERGENCY FIELD HOSPITAL TO VENEZUELA AFTER DEADLY EARTHQUAKES; 767 CARGO PLANE DEPARTS TOMORROW
SAMARITAN'S PURSE DEPLOYS EMERGENCY FIELD HOSPITAL TO VENEZUELA AFTER DEADLY EARTHQUAKES; 767 CARGO PLANE DEPARTS TOMORROW
aiku.in
health
prnewswire_all
6/26/2026
Scientology Network Presents Special Marathon for International Day Against Drug Abuse
Scientology Network Presents Special Marathon for International Day Against Drug Abuse
health
prnewswire_all
6/26/2026
NEDHSA and Redeemed at Calvary Ministries Sign Landmark Agreement to Expand Access to Harm Reduction Services in Bawcomville
NEDHSA and Redeemed at Calvary Ministries Sign Landmark Agreement to Expand Access to Harm Reduction Services in Bawcomville
health
prnewswire_all
6/26/2026
The Inner Circle acknowledges Jilian Grooms as a Pinnacle Professional Member Inner Circle of Excellence
The Inner Circle acknowledges Jilian Grooms as a Pinnacle Professional Member Inner Circle of Excellence
health
prnewswire_all
6/26/2026
The Inner Circle acknowledges Dr. Barbara Betancourt Cortes as a Pinnacle Lifetime Member
The Inner Circle acknowledges Dr. Barbara Betancourt Cortes as a Pinnacle Lifetime Member
health
prnewswire_all
6/26/2026
If Your Private Information Was Potentially Compromised in a Data Breach Announced by Drug & Alcohol Treatment Services, Inc. on December 5, 2024, You May be Eligible for Benefits from a Class Action Settlement.
If Your Private Information Was Potentially Compromised in a Data Breach Announced by Drug & Alcohol Treatment Services, Inc. on December 5, 2024, You May be Eligible for Benefits from a Class Action Settlement.
health
prnewswire_all
6/26/2026
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
theventure.in
health
prnewswire_all
6/26/2026
Mental Health Association's GOFCC Program Celebrates 100 Licensed Family Child Care Educators, Expanding Access for Families Across Western Maryland
Mental Health Association's GOFCC Program Celebrates 100 Licensed Family Child Care Educators, Expanding Access for Families Across Western Maryland
raat.in
health
prnewswire_all
6/26/2026
4e exposition internationale sur les chaînes d'approvisionnement en Chine : Healthy Life Chain dévoile son éventail d'innovations en matière de chaîne d'approvisionnement mondiale dans le secteur de la santé
4e exposition internationale sur les chaînes d'approvisionnement en Chine : Healthy Life Chain dévoile son éventail d'innovations en matière de chaîne d'approvisionnement mondiale dans le secteur de la santé
opticare.in
health
prnewswire_all
6/26/2026
Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health
Don't Miss the Moments That Matter This Summer: Hearing Experts and Cochlear Encourage People to Check Their Hearing Health
health
prnewswire_all
6/26/2026
Pediatric Occupational Therapy Expert Kathy Schleifer of Pueblo Explains Sensory Integration Therapy for HelloNation
Pediatric Occupational Therapy Expert Kathy Schleifer of Pueblo Explains Sensory Integration Therapy for HelloNation
health
prnewswire_all
6/26/2026
26Health to Offer Free HIV Testing in Orlando for National HIV Testing Day
26Health to Offer Free HIV Testing in Orlando for National HIV Testing Day
health
prnewswire_all
6/26/2026
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
health
prnewswire_all
6/26/2026
Applied ABC Launches "Mahalo ABA" in Hawaii, Bringing Clinically Led Autism Services to Children Across the Islands
Applied ABC Launches "Mahalo ABA" in Hawaii, Bringing Clinically Led Autism Services to Children Across the Islands
health
prnewswire_all
6/26/2026
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
Key Milestone Achieved: NDA for Sumecigrel Capsule, an Antiplatelet Innovative Drug by Vcare PharmaTech, Officially Accepted
wecharge.in
health
prnewswire_all
6/26/2026
RADIN Health Expands National Footprint with Four Additional Hospitals Deployed at UHS Nevada Health System
RADIN Health Expands National Footprint with Four Additional Hospitals Deployed at UHS Nevada Health System
wecharge.in
health
prnewswire_all
6/26/2026
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
Anivive Lifesciences Announces FDA Approval of Laverdia®, the First Oral Treatment of Its Kind for Canine Lymphoma
health
prnewswire_all
6/26/2026
Hivelocity Launches Healthcare Bundle -- Bare Metal Infrastructure for the HIPAA Program You Operate
Hivelocity Launches Healthcare Bundle -- Bare Metal Infrastructure for the HIPAA Program You Operate
precast.in
health
prnewswire_all
6/26/2026
Texas Cardiac Arrhythmia Institute organiza una conferencia sobre arritmias cardíacas complejas
Texas Cardiac Arrhythmia Institute organiza una conferencia sobre arritmias cardíacas complejas
health
prnewswire_all
6/26/2026
Texaský institut pro srdeční arytmie při St. David's Medical Center uspořádal mezinárodní konferenci o složitých srdečních arytmiích
Texaský institut pro srdeční arytmie při St. David's Medical Center uspořádal mezinárodní konferenci o složitých srdečních arytmiích
health
prnewswire_all
6/26/2026
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split
wecharge.in
health
prnewswire_all
6/26/2026
Largest Nurse and Healthcare Professional Strike in Massachusetts History Scheduled for July 8 as 4,500 MNA Nurses and Clinicians Plan Walk Out at Brigham and Women's Hospital and MGB Home Care
Largest Nurse and Healthcare Professional Strike in Massachusetts History Scheduled for July 8 as 4,500 MNA Nurses and Clinicians Plan Walk Out at Brigham and Women's Hospital and MGB Home Care
health
prnewswire_all
6/26/2026
Texas Cardiac Arrhythmia Institute при St. David's Medical Center провел международную конференцию по сложным видам аритмии сердца
Texas Cardiac Arrhythmia Institute при St. David's Medical Center провел международную конференцию по сложным видам аритмии сердца
health
prnewswire_all
6/26/2026
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
creditmart.in
health
prnewswire_all
6/26/2026
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year
health
prnewswire_all
6/26/2026
The Doctors Company Completes Acquisition of ProAssurance Corporation
The Doctors Company Completes Acquisition of ProAssurance Corporation
health
prnewswire_all
6/26/2026
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
Anixa Biosciences Reports Positive Data from Completed Breast Cancer Vaccine Phase 1 Trial and Positive Survival Observations from Ongoing CAR-T Phase 1 Trial at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
health
prnewswire_all
6/26/2026
Nippon Shinyaku and Elixirgen Therapeutics Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
Nippon Shinyaku and Elixirgen Therapeutics Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy
wecharge.in
health
prnewswire_all
6/26/2026
Local Orthopedic Surgeon First in Area to Use New Treatment Option for Complex Shoulder Surgery
Local Orthopedic Surgeon First in Area to Use New Treatment Option for Complex Shoulder Surgery